Asia 2003-05-01 Staff Writer <strong>AsiaMonitor</strong><br> <sec level="2"><strong>Carving a niche</strong><br> <bold>The mezzanine market in Asia remains in its infancy, but a couple of players are determined to be first in line to bridge the funding gap i
10 min read · 12 January 2013
Americas 2003-05-01 Staff Writer <strong>AmericaMonitor</strong><br> <sec level="2"><strong>The operating guys</strong><br> <bold>Buyout firms are going out of their way to prove to investors that they have the necessary operational expertise to improve the b
10 min read · 12 January 2013
The US buyout firm is in talks with a consortium of banks to ensure necessary funding is in place for its bid for the UK supermarket chain.
2 min read · 12 January 2013
Through his investment business EXOR, the legendary Fiat chairman and industrialist, who has died aged 81, played an important role in private equity spanning three decades.
3 min read · 12 January 2013
GE Commercial Finance has made two further appointments at its European leveraged finance team as it looks to double its activity in the European mid-market.
2 min read · 12 January 2013
Europe 2003-04-01 Staff Writer <strong>Europe<br> Deals & Exits</strong><br> <sec level="2"><strong>Investment up while fundraising slows</strong><br> European private equity investment reached its second highest annual level last year, according to data
10 min read · 12 January 2013
Americas 2003-03-01 Staff Writer <strong>AmericaMonitor</strong><br> <sec level="2"><strong>The Benz factor</strong><br> <bold>Auto industry executives know something about secondary transactions which private equity professionals might want to pay attention
10 min read · 12 January 2013
Equity for the E3.7bn acquisition of Legrand is provided by a group of sponsors led by KKR and Wendel and including HSBC, West LB and Goldman Sachs Capital Partners.
2 min read · 12 January 2013
The Charme funda, a fund targeting Italian consumer brands and products, has held a first close at E110m.
2 min read · 12 January 2013
US private equity house Behrman Capital has paid $122m for the lab testing services division of Irish pharmaceutical business Elan Corp.
2 min read · 12 January 2013